Fundraising Fox
Spirea
8 employees on LinkedIn · 8 known investors
Find your way into Spirea
Sign up to see every warm intro you have to Spirea
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spirea team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Spirea develops a multivalent ADC linker technology called ELIVATE that expands the range of usable payloads for antibody-drug conjugates, aiming to enable next-generation ADCs for oncology, inflammation, and autoimmune diseases. The company develops proprietary linker-payloads and offers ADC design and conjugation expertise for partnering with pharmaceutical and biotech companies.
Founders & leadership
Investors · 8
How we know: Cambridge Angels group's portfolio page · techgistafrica.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Start Codon's portfolio page · Not right? Tell us
How we know: techgistafrica.com · funding news · Not right? Tell us
How we know: o2hventures.com · funding news · Not right? Tell us
How we know: techgistafrica.com · funding news · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingDec 2020
o2h ventures (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Spirea do?
- Spirea develops a multivalent ADC linker technology called ELIVATE that expands the range of usable payloads for antibody-drug conjugates, aiming to enable next-generation ADCs for oncology, inflammation, and autoimmune diseases. The company develops proprietary linker-payloads and offers ADC design and conjugation expertise for partnering with pharmaceutical and biotech companies.
- Who founded Spirea?
- Spirea was founded by Myriam Ouberai.
- Who are Spirea's investors?
- Spirea's investors include Cambridge Angels group, Start Codon, ACF Investors, O2h Ventures, R42 Group.